Introduction: There is a high rate of recurrence of tear and failed healing after rotator cuff repair. Several strategies have proposed to augment rotator cuff repairs to improve postoperative outcome and shoulder performance. We systematically review the literature on clinical outcome following rotator cuff augmentation.
Introduction
Rotator cuff tears are the most important cause of shoulder disability, accounting for 4 500 000 specialist visits and over 250 000 surgical procedures performed in the USA every year. 1 Despite recent improvements in the surgical technique to repair the tears, recurrence or incomplete healing rates ranging from 40 to over 90% continue to be reported. 2, 3 Large and massive rotator cuff lesions lead to worse clinical outcomes than partial and small defects, especially when the lesion is old and intrinsic tendon degeneration is present. 4, 5 After a chronic and massive rotator cuff tear, the tendon loses elasticity since it is replaced by stiffer, mechanically inferior scar tissue. The goal of the repair is a strong tendon-to-bone healing to restore the original biology and biomechanics of the native rotator cuff footprint. 6 A tendon which is poorly reducible produces a weak repair, with consequent impaired strength and range of motion. 7 Therefore, there is a growing need to develop new strategies and materials to mechanically improve the surgical repair of larger tears in order to achieve better function and reduce the disrupting forces borne by the restored tissues. At the same time, an effective enhancement of the tendon healing process should be aimed to reach the best possible postoperative outcome. 8 It is of potential clinical interest to investigate devices enhancing the healing of a rotator cuff tear treated by surgical means. An effective augmentation of the restored structures can be achieved through the use of adjuvant factors to promote biologic healing, mechanical scaffolds that reinforce repairs and promote fibroblast migration and ingrowth and other types of mechanical scaffolds that bridge the areas of tendon defect, just to name a few. Biological approaches have been the most common strategy investigated to date. 9 Several studies have been published over the last decades to demonstrate the biomechanical, histological and clinical effectiveness of different classes of augmentation devices. A few recent reviews described the results of isolated methods to augment the repair of rotator cuff tears. 9 -13 To our knowledge none of them comprehensively analyzed and compared the outcomes of all the classes of augmentation devices used to date on surgical practice. We therefore examined all the best evidence on the different classes of augmentation devices for rotator cuff repairs to try to answer the following questions: † What are the main effects and characteristics of the tissues/materials currently available for augmentation of rotator cuff repair? † Are there considerable clinically relevant differences between rotator cuff repairs with or without augmentation when compared? † Does augmentation lead to acceptable clinical outcome also for the repair of massive tears of the rotator cuff? † Which is the level of the available evidence on this issue?
Methods

Search strategy
A search for useful and relevant studies was conducted. Pub Med (http://www.ncbi.nlm.nih.gov/sites/entrez/), Google Scholar (http:// scholar.google.it/), CINAHL (http://www.ebscohost.com/cinahl/), Cochrane Central (http://www.thecochranelibrary.com/view/0/index. html/) and Embase Biomedical (http://www.embase.com/) databases were accessed on 20 June 2012 using the isolated or combined keyword 'augmentation and rotator cuff'; 'biologic augmentation and rotator cuff'; 'dermal augmentation and rotator cuff'; 'synthetic augmentation and rotator cuff'; 'tissue engineering and rotator cuff'; 'cellular devices and rotator cuff'; 'graft augmentation and rotator cuff'; 'patch augmentation and rotator cuff' with no limits regarding the year of publication.
Criteria for consideration
Given our language capabilities, we considered publications in Italian, Spanish, French and English.
At the first electronic search, we identified 112 relevant publications. Two authors (R.P. and S.D.A.) independently reviewed the content of each abstract. Once an article was identified as likely to be included, full-text versions were obtained to evaluate the exact content of the study. The reference lists of the selected articles were then examined by hand to identify articles not identified at the electronic search. All journals were considered and all relevant articles were retrieved.
Studies focusing on clinical outcomes of patients who had undergone rotator cuff repair augmented with any device were selected. Biomechanical reports, studies on animals, cadavers, in vitro, case reports, literature reviews, technical notes, letters to editors, instructional course and studies focusing only on complications were excluded.
Data extraction
Forty articles investigating patients' outcomes following augmentation of rotator cuff surgical repairs were included. To avoid bias, all these articles were reviewed and discussed by all the authors: we decided to exclude three articles because they were case reports. We considered tendon transfer as a surgical technique rather than an augmentation strategy: for this reason, five more publications were excluded. On the other hand, we decided to include studies investigating tendon transplants which we recognized suitable to be defined as augmentation devices. Eventually, 32 publications relevant to the topic at hand were included (Fig. 1) .
Quality assessment
To evaluate the methodological quality of each article, two investigators (R.P. and S.D.A.) separately evaluated each article using the Coleman methodology score (CMS), 14 a 10 criteria scoring list assessing the methodological quality of the selected studies (CMS). Each study was assessed for each of the 10 criteria to give a final score ranging from 0 to 100 (Table 2 ). An investigation scoring 100 would represent a perfect study design with no influence of chance, various biases and confounding factors. The two investigators discussed scores where more than a two-point difference was evident, until consensus was reached. Additionally, we recorded age, gender, devices used and surgical technique. 
Results
Number and type of studies Thirty-two articles were included in the present review: 2 were retrospective studies 15, 16 and 30 were prospective 17 -46 . All studies focused on the clinical and/or radiographic outcome of differently augmented surgical repairs of the rotator cuff.
Pre-operative features
The mean reported age at the time of surgery was 59.8 years (range: 48.0 42 to 67.5 16 ).
Study population
The total number of all patients receiving the augmentation and studied was 873 (males: 456; females: 327; sex was not reported in the remaining patients). The average follow-up length was 29.5 months ( Table 1 ). The mean modified CMS was 64.0 (range from 45 38 to 88 24 ). The categories, size of the study, description of postoperative rehabilitation and description of the subject selection process had the lowest mean values. The average total CMS and the average CMS for each criterion are given in Table 2 .
Years of publication
The CMS shows an evidence of a statistically significant association with the publication year (r ¼ 0.59; P ¼ 0.003). This could be explained by advances in research methodology, allowing recent studies to be better refined and clinically more relevant than some pioneering studies included in this review.
Subject selection
Fifteen of the 32 (46.8%) selected studies satisfactorily described subject selection criteria, 28 studies (87.5%) used validated scoring systems with good reliability and sensitivity, while 22 studies (68.7%) had sufficient scored procedures to assess final outcomes. (Table 3) .
Outcome measures
The most commonly used rating scales were UCLA (University of California at Los Angeles) score which was used in 11 of the 32 studies (34.3%), 19 20, 23, 26, 31, 39, 43 In the six studies (20.0%), 34, 35, 38, 44, 45 the outcome was assessed only by surgeon's opinion after clinical examination without the help of standard scales (Fig. 2) .
Classification of devices
Biologic, synthetic and cellular devices were used in 24 (75%), 7 (21.8%) and 1 (3.1%) studies, respectively. Among biological tissues, 10,15,20 -22,24,31,39 -41,43 devices were autogenic, 5 were xenogenic, 16, 18, 29, 37, 45 while 9 were allogenic. 19, 23, 27, 30, 32, 34, 35, 42, 46 The devices most frequently used for augmentation were platelet-rich plasma (PRP) in seven articles 20 Rotator cuff augmentation and replacement using GraftJacket allograft (acellular human dermal matrix) , using a PRP fibrin matrix (PRPFM), found at magnetic resonance imaging (MRI) a lower percentage of re-tears in the PRPFM-augmented group compared with a control group. No statistically significant difference was detected between the two groups in most of the clinical outcome scores measured (ASES, SANE, SST and Constant). Only the Rowe score improvement was found to be 39, 40 performed two studies on autologous PRP use for rotator cuff repair. In a pilot study, 40 they applied PRP intra-operatively with an autologous thrombin component with encouraging results in terms of reduction of visual analogic scale (VAS) of pain, and increase of UCLA and Constant scores (P 0.001). No adverse events after application of PRP during rotator cuff repair were detected. Later, they performed a prospective randomized controlled trial (RCT) 39 with 2 years of follow-up reporting the reduction of pain 30 days after the surgery (P , 0.05) in the treatment group. When compared 6, 12 and 24 months after the procedure, the treatment group and the control group show no difference in terms of UCLA and Constant score, but only strength in external rotation was significantly increased in the treatment group (P , 0.05).
Castricini et al., 24 in a 16-month RCT, reported no difference between the treatment and control groups in clinical (Constant score improved from 42.9 to 88.4) and imaging (P ¼ 0.07) outcomes for small and medium rotator cuff lesions. Therefore, they did not support the use of intra-operative PRP (PRFM) in small or medium rotator cuff tears repaired with a double-row technique. Given the data they also hypothesized that in large and massive rotator cuff lesions, the use of intra-operative PRP (PRFM) could achieve best results.
Jo et al., 31 in a their prospective cohort study, investigated 42 patients with a full-thickness rotator cuff tears divided in two groups. They found similar outcomes in the PRP-application group and the non-augmented group in terms of ASES score, Constant score, UCLA score, Disabilities of the Arm, Shoulder and Hand (DASH) score, Simple Shoulder Test (SST) score and Shoulder Pain and Disability Index (SPADI) score. A non-significant (P ¼ 0.388) lower re-tear rate was shown at MRI investigations in the experimental group.
Bergerson et al., 22 in a their cohort study, showed equivalent results according to tear size between the platelet-rich fibrin matrix (PRFM) augmented group and the control group in terms of Goutallier scores, but they recorded a statistically higher (P ¼ 0.024) re-tear rate in the PRFM group.
Most recently, Rodeo et al. 41 investigated the use of the same fibrin matrix drawing the same conclusions: the patients who received the augmented procedure failed to show ultrasonographic evidence at 12 weeks follow-up of greater tendon healing than patients treated in the control group (P ¼ 0. 20) . No relevant differences between the two groups were found in the remaining outcome scores measured (ASES, L'Insalata score and muscle strength). Both groups showed the same vascularity rate in the peribursal, peritendinous and musculotendinous areas of the repaired shoulder. This study confirms the conclusions by Castricini et al.
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Other autograft Autograft augmentations were investigated in three further more studies. 15, 21, 43 Scheibel et al. 43 reported that augmentation with an autologous periosteal flap achieved good postoperative results measured with Constant (from 51.7 to 80.9 points (P , 0.05) and SST (P , 0.05) scores. A re-tear of the rotator cuff was observed in four patients. In addition, four patients developed ectopic ossifications in the supraspinatus tendon without clinical consequence.
Sano et al. 15 transplanted the long head of the biceps to repair irreparable massive rotator cuff tears in 14 patients. They demonstrated a postoperative improvement of the Japanese Orthopaedics Association (JOA) score (from 54.7 points to 83.1 points), active elevation angle (from 69 + 44 to 149 + 17) and at imaging assessment with MRI T2-weighted in terms re-tearing.
Bektaşer et al., 21 using a free coraco-acromial ligament graft as augmentation of massive rotator cuff tears, obtained higher results in postoperative flexion (from 27.58 to 102.68), in postoperative abduction (from 22.58 to 96.58), postoperative Constant score (from 45 to 80) and good ultrasonographic outcome in terms of tendon integrity and thickness.
Xenograft
Porcine xenograft devices were utilized in five studies. 16, 18, 29, 37, 45 Badhe et al. 18 used a porcine dermal collagen patch to cover large tendinous lesion when the tear could not be sutured given the excessive tension from due to tendon retraction. No complications occurred, and the Constant score greatly improved at the final follow-up 3-5 years later by 20 points. All score subcategories showed better outcome.
Walton et al. 45 performed a conventional repair augmented with a porcine SIS patch. They recorded 4 inflammatory reactions in 10 patients who had undergone the procedure. The patients in addition to adverse reactions experienced significantly lower pain relief, poor lift-off, internal rotation and adduction strength, and a higher rate of impingement in external rotation when compared with a control group who underwent conventional repair matched by demographics. Therefore, they do not recommend the use of this device.
Similar rate of complications and poor outcomes were experienced by the patients treated with the same device in the RCT by Iannotti et al., 29 the retrospective study by Sclamberg et al. 16 and the study by Phipatanakul and Petersen. 37 
Augmentation techniques for rotator cuff repair
British Medical Bulletin 2013;105
Iannotti et al. 29 showed how augmentation with porcine SIS often had no imaging evidence of complete healing of the cuff defect ( 75% of the cases), and of the measured Penn Shoulder score (a 100-point shoulder-specific self-report questionnaire consisting of three subscales of pain, satisfaction and function), evidencing that the control group had better outcomes postoperatively. Sclamberg et al. 16 also showed a re-tear on the MRI in 10 of the 11 patients treated for large tears. There was no statistically significant difference between the preoperative and postoperative shoulder scores (ASES), and five patients had worse scores 6 months after the surgery. Finally, Phipatanakul and Petersen 37 reported clinical improvement as measured by postoperative values of UCLA (11.8 points increase), ASES (35.5 points increase) and pain score (4.6 points improvement). However, they found suboptimal imaging support. Partial or complete healing of the tear was seen in only 44% of the patients, and three adverse reactions occurred in a cohort of 11 patients.
Allograft
Augmentation by transplantation of different allograft was studied in nine series. 19, 23, 27, 30, 32, 34, 35, 42, 46 Neviasier et al. 35 in 1978 implanted a freeze-dried rotator cuff from cadavers in 16 shoulders with chronic massive ruptures of the cuff to bridge the defect; no standardized score was measured, but very good functional results were achieved in all but two patients while pain relief was obtained in all of them. Nasca, 34 a decade later, used the same approach in his cohort, reporting less significant improvements than the previous study in the seven patients treated with this patching technique in terms of muscular strength and range of motion. Grafting failure occurred in two patients, and needed a new surgical repair.
Ito and Morioka 30 used a double layer of freeze-dried fascia lata for the surgical management of large and massive tears when a conventional repair could not be performed due to the unfeasibility of attaching the end of the cuff to the anatomical portion of the humeral head. Other than the slightly better outcomes measured with JOA scores in the treated group compared with the control, a re-tear occurred in 3 of the 17 control patients, while no failure was found in the patch group at the final follow-up 3 years later.
Moore et al. 32 repaired massive rotator cuff tears in 32 patients using different allografts (quadriceps tendon, patellar tendon, Achilles tendon) interposition when a tension free repair could not be obtained. UCLA clinical scores were good or excellent in 53% of the 28 patients with a minimum of 6 months follow-up. Eighteen percent of the cohort had a poor outcome. However, all patients in whom the MRI evaluation was performed demonstrated a complete failure of allograft implants, with no allograft tissue remaining in continuity with the greater tuberosity, and concomitant superior translation of the humeral head.
A human dermal matrix was used in the preliminary clinical study performed by Rotini et al., 42 in an RCT by Barber et al. 19 and in further studies by Bond et al., 23 Wong et al. 46 and Gupta et al.
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; they demonstrated that this type of augmentation can bring a good contribution to tendon healing.
Rotini et al. 42 showed an increase in the Constant score and a total absence of adverse septic or inflammatory effects after procedures augmented with a human dermal matrix scaffold. In the five patients followed up for 1 year, they reported three patients with complete healing, one partial re-tear and one total recurrence.
In the study of Barber et al., 19 patients receiving the Graftjacket device presented higher postoperative ASES (from 48.5 to 98.9, P ¼ 0.035), Constant (from 41.0 to 91.9, P ¼ 0.008) and UCLA score (13.3 to 28.2, P ¼ 0.43) and better MRI outcomes in terms of intact cuffs than the control group.
Wong et al. 46 showed an increase in UCLA (18.4 -27.5, P , 0.000), ASES (84.1 at the final follow-up) and WORC index (Western Ontario Rotator Cuff ) (75.2 at the final follow-up) after the repairs in patients treated with Graftjacket compared with the control group.
The Graftjacket used by Bond et al., 23 in addition to the higher UCLA (from 18.4 to 30.4, P ¼ .0001) and the higher Constant score (from 53.8 to 84.0, P ¼ 0.0001), produced full incorporation of the graft into native tissue by imaging radiological assessment in over 70% of patients, and statistically significant improvements in terms of pain, forward flexion and external rotation strength.
Gupta et al. 27 also reported outcomes obtained after massive irreparable rotator cuff repair augmented with a human dermal matrix allograft, reporting satisfactory improvements in VAS (P ¼ 0.0002), ASES (P ¼ 0.0003), SF-12 scores (P ¼ 0.03) and in all ranges of motion, pain and muscle strength.
Synthetic devices outcome data
Seven studies 17, 26, 28, 33, 36, 38, 44 used different materials to produce a patch useful in the repair of large and massive tendinous tears that could not be easily sutured. These grafts were therefore mainly used to bridge the edges of otherwise irreparable lesions (Table 5) .
Ozaki et al. obtaining good functional results. Twenty-three of the 25 patients who underwent the surgery regained a good range of motion (120-1608 of abduction). Pain relief was also remarkable, since the same patients just mentioned above were completely free from it at the follow-up.
Visuri et al. 44 performed an open reconstruction using a carbon fiber tow to mostly achieve realize a partial cover of the cuff defect, with good results in 11 of the 14 patients. In fiv patients, the good results had been maintained over a 5-year follow-up. They also reported imaging and histological evidence of collagen ingrowth over the device, which justified their support of this device.
Post 38 repaired large tears with the surgical application of the carbon filament-polylactic acid (CPA) stent to suture the tear, reporting postoperative good to excellent results in three of the five patients treated. The average increase in the range of motion was 508. The benefit in the muscle strength was also noted but the difference between preoperative and postoperative values was dramatic only in one case. One failure was reported due to stitch abscess.
Interposition of the mersilene mesh patch on massive tears combined with subacromial decompression was performed in the study by Audenaert et al. 17 The patients showed a promising average increase of 46.4 points on the Constant score (P , 0.001) following surgery. It should be noted however that the absence of a control group makes it difficult to distinguish how much of the improvements achieved are actually related to the use of the device rather than to the subacromial decompression associated with the repair.
Encalada Diaz et al. 26 used a biocompatible polycarbonate polyurethane-urea as a scaffold to augment the repair of small and medium tears. Promising clinical results were reported at 12 months evaluation as measured by all the main subjective shoulder surveys such as UCLA, ASES (mean improvement 29.7), SST (mean improvement 4.1) and VAS (mean improvement 2.9) (P , 0.01). Additionally, MRI and Ultrasound (Sonography, US) showed healing in 90% of patients at follow-ups. Nada et al. 33 published the results of massive tears repaired by using a Dacron polyester ligament to restore the normal anatomy of the injured rotator cuff by holding it onto its original footprint. They measured outcomes of the 21 patients over 3 years and all but one had considerable pain relief and average increase of the Constant score (P , 0.001) was an excellent (37.8) . The fatty degenerative changes in infraspinatus and subscapularis following the procedure did not seem to influence the final clinical outcome.
Hirooka et al. 28 used a Goretex patch to reconstruct tears of the rotator cuff that could not be sutured, and evaluated the outcome with the JOA score (P , 0.0001). The pain score showed the highest improvement (18.7 points average). Function and ROM also improved significantly, but not as much as pain. There were no significant differences in the improvement between the small-patch and the large-patch groups.
Cellular devices outcome data
Only one study in this review employed tissue engineering techniques to produce and utilize a cellular augmentation device 25 to augment surgical repair (Table 5) .
Ellera Gomes et al. 25 associated conventional rotator cuff reconstruction with the implantation of autologous BMMC (bone marrow mesenchymal cells). Using a trans-osseous repair technique, stem cells were injected over the tendon margins to enhance tendon regeneration. Clinically, promising outcomes were recorded when compared with historical data available for patients undergoing the same surgical procedure without the addition of stem cells. The most valuable findings were an average increase of 19 points at UCLA scores 12 months postoperatively, and evidence of newly formed healthy tendon tissue at imaging examinations on the site of cells implant.
Discussion
Several augmentation techniques have been proposed to improve tendon healing in rotator cuff tears. 11, 47 We conducted this systematic review to examine the best evidence on the use of augmentation devices presently available for surgery of rotator cuff tears, especially chronic and massive tears. We performed a comprehensive search, and we evaluated the methodological quality of the studies with the CMS. The CMS score was originally developed to assess the methodological quality of studies investigating the clinical outcomes of patients with patellar tendinopathy, 48 and it has been subsequently used and validated for a variety of other conditions, such cartilage injuries, 49 posterior cruciate ligament, 50 achilles tendinopathy, 14 knee arthroplasty, 51 cervical spine fracture 52 and combined anterior cruciate and medial collateral ligaments injury. 53 Analyzing the role of augmentation, we tried to answer the following questions. † What are the main effects and characteristics of the tissues/materials currently available for the augmentation of rotator cuff repair?
Biological devices should be evaluated according to their nature. PRP-related and other autograft devices 15,20 -22,24,31,39,40,41,43 are free from adverse reaction, and they can positively influence the rate of re-tear. Xenografts 16, 18, 29, 37, 45 show a concerning wide range of complications, while allografts seem to be a good compromise. Synthetic patches 17, 26, 28, 33, 36, 38, 44 were effective for reconstruction of large rotator cuff tears, restoring good functionality, although the level of evidence supporting this conclusion is very low (levels III and IV), and some of the studies are dated. 36, 38 Finally, tissue engineering solutions such as BMMSC, report promising clinical results, and are believed to be the future to augment rotator cuff repairs, given their ability to differentiate in original tendon cells, but the evidence is still poor. † Are there considerable clinical differences between rotator cuff repairs with or without augmentation when compared?
Only 10 studies compared results between augmented procedures and conventional repairs. 19,20,22,24,29 -31,39,41,45 Barber et al. 20 is the only one to support the evidence of significantly better clinical outcomes after a procedure augmented with a biologic device (PRPFM) over a standard rotator cuff repair, although their study is not an RCT. The remaining studies 19,22,24,29 -31,39,41,45 showed no relevant difference in terms of improved clinical outcome between treated groups and controls.
Moreover, the augmentation was tested mostly in large and massive and/or irreparable rotator cuff tears, 15 -19,21,23,25,27 -30,32 -38,42,44 -46 while the remaining studies 20,22,24 -26,31,39,40,41,43 focused on small, medium or unspecified lesions.
We do not know whether the procedures are more effective on particular types of lesions rather than others, because none of the reviewed studies compared the results of augmentation strategies in a population with different types and extension of tears. Future works should focus on comparative studies of the effects obtained, thanks to the selected augmentation device in different types of lesions. This would allow readers to draw clear conclusions for everyday clinical use. † Does augmentation lead to acceptable clinical outcome also for the repair of massive tears of the rotator cuff?
As conventional repairs of large and massive tears do not produce enduring clinical outcome, 4, 5 given the high recurrence rate, a patch or a graft can be a good solution to cover the defect. The synthetic augmentation devices reviewed were mostly experimented for this type of lesion together with most of the biological tissues experimented so far, showing good early clinical and imaging outcomes, but equivalent long-term re-rupture evidence compared with simple reconstruction. The main advantage of these devices is the ability to produce less tension on the footprint compared with a conventionally sutured cuff, but this is not enough to achieve a significant decrease in the chance of re-tear in the future. † Which is the level of the available evidence on this issue?
The relatively low average of CMS scores (64.0) of the clinical studies demonstrate only acceptable quality of the studies included in this systematic review. Another major concern is the lack of an appropriate number of randomized controlled trials, 19, 39, 41 even though most of the studies examine the cohorts prospectively, and just a few studies are retrospective. 15, 16 Except for UCLA 19, 22, 23, 25, 26, 31, 32, 37, 39, 40, 46 and Constant 17,18,20 -24,28,31,33,39,40,42,43 scores which were used by most of the authors making their outcome comparable with other studies, heterogeneity of the other clinical outcome scores makes it difficult to undertake a comparative analysis among different results. Moreover, some studies did not include imaging assessments, and, if this was undertaken, they focus on differing aspect of healing process.
In conclusion, none of the augmentation devices available is flawless, and each one presents intrinsic weakness. There is no dramatic increase in clinical and functional assessment after augmented procedures, especially if compared with control groups treated with conventional surgical procedures. Finally, given the high costs and the technical difficulties, we need more and better scientific evidence to support the routine use of augmentation in rotator cuff repairs.
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